InsiderSignal.AI

InsiderSignal.ai

CLDI - Calidi Biotherapeutics, Inc.

Insider Purchase by Leftwich Scott (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

6 months ago, Leftwich Scott, serving as Dir at Calidi Biotherapeutics, Inc. (CLDI), purchased 125,000 shares at $2.00 per share, for a total transaction value of $250,000.00. Following this transaction, Leftwich Scott now holds 146,631 shares of CLDI.

This purchase represents a 578.00% increase in Leftwich Scott's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 21, 2025 and publicly disclosed via SEC Form 4 filing on Monday, August 25, 2025, 4 days after the trade was made.

Calidi Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Leftwich Scott

Leftwich Scott

Dir

Scott Leftwich is an Independent Vice-Chairman of the Board and Director at Calidi Biotherapeutics, Inc. (CLDI), a position he has held since joining the Board in May 2019 as Vice-Chairman.[[1]](https://www.calidibio.com/team/scott-leftwich/)[[2]](https://rocketreach.co/scott-leftwich-email_11467840)[[4]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nysemkt-cldi/calidi-biotherapeutics/management) He owns approximately 146,631 shares of CLDI stock, valued at over $171,558, and recently purchased 75,000 shares on August 21, 2025, at $2.00 per share.[[3]](https://www.gurufocus.com/insider/235739/scott-leftwich)[[5]](https://www.otcmarkets.com/stock/CLDI/disclosure) Leftwich brings extensive executive experience in healthcare, software, and security sectors. He served as CEO of InterMedHx (2011-2014), acquired by Cerner Corporation, COO of Anakam (2005-2010), acquired by Equifax, and COO of an education company that grew from $10 million to over $60 million in revenue.[[1]](https://www.calidibio.com/team/scott-leftwich/) Earlier, he owned a consulting firm advising Hospital Corporation of America (HCA) and spent 15 years as a U.S. Navy P-3 pilot, rising to Commander with global missions and a White House assignment.[[1]](https://www.calidibio.com/team/scott-leftwich/) He holds an MBA with honors from Harvard Business School and a BS with distinction from the U.S. Naval Academy.[[1]](https://www.calidibio.com/team/scott-leftwich/)

View full insider profile →

Trade Price

$2.00

Quantity

125,000

Total Value

$250,000.00

Shares Owned

146,631

Trade Date

Thursday, August 21, 2025

185 days ago

SEC Filing Date

Monday, August 25, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Calidi Biotherapeutics, Inc.

Company Overview

No company information available
View news mentioning CLDI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/154722

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime